Acadia Healthcare (ACHC) to Release Earnings on Thursday

Acadia Healthcare (NASDAQ:ACHC) is projected to issue its quarterly earnings data after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of $0.75 per share and revenue of $778.98 million for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Acadia Healthcare Trading Up 4.1 %

NASDAQ:ACHC opened at $42.35 on Wednesday. Acadia Healthcare has a 52 week low of $36.50 and a 52 week high of $87.77. The firm has a 50 day moving average of $42.18 and a 200 day moving average of $52.38. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock has a market capitalization of $3.93 billion, a price-to-earnings ratio of 13.89, a PEG ratio of 1.46 and a beta of 1.30.

Analyst Ratings Changes

A number of research firms have recently weighed in on ACHC. TD Cowen cut their price objective on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research note on Tuesday, January 7th. KeyCorp raised shares of Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 price objective on the stock in a report on Tuesday, January 7th. Royal Bank of Canada reissued an “outperform” rating and issued a $64.00 price target on shares of Acadia Healthcare in a research note on Friday, January 10th. StockNews.com downgraded shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price target for the company from $45.00 to $75.00 in a research report on Thursday, December 12th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $70.22.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.